...
首页> 外文期刊>European journal of drug metabolism and pharmacokinetics >Preparation and in vitro/in vivo evaluation of felodipine nanosuspension
【24h】

Preparation and in vitro/in vivo evaluation of felodipine nanosuspension

机译:非洛地平纳米混悬剂的制备及体外/体内评价

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The purpose of this study was to develop a nanosuspension of a poorly soluble drug felodipine by nanoprecipitation to achieve superior in vitro dissolution and high oral absorption in vivo in rats. Felodipine nano-suspensions were prepared by precipitation with ultrason-ication method using polyvinyl alcohol (PVA) and hydroxy propyl methyl cellulose (HPMC) as stabilizers. The particle size of nanosuspension with PVA was 60-200 nm, while with HPMC is 300-410 nm. The in vitro dissolution and pharmacokinetics of optimized nanosuspensions were studied after oral administration in male wistar rats. The results showed significant improvement during in vitro dissolution and in vivo plasma level. Dissolution studies of lyophillised nanoparticles showed that up to 93.0 % dissolved in 2 h. In the in vivo evaluation, nanosuspension exhibited significant increase in AUC0_24, Cmax and decrease in tmax. The findings revealed that particle size reduction can influence felodipine absorption in gastrointestinal tract and nanosuspension can enhance oral bio-availability of felodipine in rats.
机译:这项研究的目的是通过纳米沉淀开发难溶性药物非洛地平的纳米混悬剂,以在大鼠中实现优异的体外溶出度和体内高口服吸收率。使用聚乙烯醇(PVA)和羟丙基甲基纤维素(HPMC)作为稳定剂,通过超声沉淀法制备非洛地平纳米混悬剂。 PVA纳米悬浮液的粒径为60-200 nm,而HPMC纳米悬浮液的粒径为300-410 nm。在雄性Wistar大鼠中口服给药后,研究了优化的纳米悬浮液的体外溶出度和药代动力学。结果显示了在体外溶出和体内血浆水平方面的显着改善。冻干纳米颗粒的溶解研究表明,在2小时内溶解高达93.0%。在体内评估中,纳米悬浮液的AUC0_24,Cmax和tmax均降低。研究结果表明,减小粒径可影响非洛地平在胃肠道的吸收,纳米悬浮液可增强非洛地平在大鼠中的口服生物利用度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号